The Asia Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Reporter.

Press releases published on April 20, 2026

Apr. 20, 2026

Rascals Is On A Mission to Help Parents Sleep Better

Indeterminate GlobeNewswire

Apr. 20, 2026

TripleDart Releases 2026 State of SaaS PPC Benchmark Report Based on $60M+ in Managed Ad Spend

Indeterminate GlobeNewswire

Apr. 20, 2026

Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics

Indeterminate GlobeNewswire

Apr. 20, 2026

WeRide’s WRD 3.0 Makes History as the Only Four‑Time Champion at China Urban Intelligent Driving Competition

Indeterminate GlobeNewswire

Apr. 20, 2026

Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Tanbreez Mining Greenland A/S Appoints Thomas “TYT” Mogensen as Chief Executive Officer

Indeterminate GlobeNewswire

Apr. 20, 2026

YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

Indeterminate GlobeNewswire

Apr. 20, 2026

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

Indeterminate GlobeNewswire

Apr. 20, 2026

Global Uranium Completes Phase 1 Earn-In at Astro Project and Secures Initial 20% Interest

Indeterminate GlobeNewswire

Apr. 20, 2026

COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations

Indeterminate GlobeNewswire

Apr. 20, 2026

Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

Apr. 20, 2026

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Indeterminate GlobeNewswire

Apr. 20, 2026

Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction

Indeterminate GlobeNewswire

Apr. 20, 2026

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

Indeterminate GlobeNewswire

Apr. 20, 2026

VVC Grants Options

Indeterminate GlobeNewswire

Apr. 20, 2026

ZJK Industrial Co., Ltd. Advances Localization Strategy in Vietnam to Strengthen Global Production Network

Indeterminate GlobeNewswire

Apr. 20, 2026

Genius Group Receives ICC Arbitration Award, Wins Return of 7.4 Million Shares and $8.0 Million Cash Payment

Indeterminate GlobeNewswire